You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 19, 2025

Patent: 10,226,550


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,226,550
Title:Cationic steroidal antimicrobial compositions for the treatment of dermal tissue
Abstract: This disclosure relates to dermal treatment compositions, such as dermal fillers and tissue glues, and injectable compositions that incorporate one or more cationic steroidal antimicrobials (CSAs). The CSAs are incorporated into the dermal treatment compositions to provide effective antimicrobial, anti-inflammatory, analgesic, anti-swelling and/or tissue-healing properties. A treatment composition includes a component formed from a biologically compatible material suitable for injection into and/or application onto tissue at a treatment site. One or more CSA compounds are mixed with the biologically compatible material so that the one or more CSA compounds are incorporated within the composition, forming a reservoir of CSA compounds within the resulting bolus of the treatment composition after injection and/or application.
Inventor(s): Savage; Paul B. (Mapleton, UT), Genberg; Carl (Las Vegas, NV), Bracken; Ronald (Monroe, GA)
Assignee: BRIGHAM YOUNG UNIVERSITY (Provo, UT)
Application Number:15/454,135
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,226,550

Introduction

United States Patent 10,226,550 (hereafter "the '550 patent") represents a significant milestone within its respective technological domain. Issued in 2019, the patent covers novel methods and systems that aim to enhance specific functionalities—most notably within the realm of biomedical devices, data processing, or chemical compositions, depending on the specific patent field. A detailed analysis of its claims, scope, and surrounding patent landscape reveals strategic insights relevant for innovators, patent practitioners, and corporate decision-makers.

This analysis dissects the patent claims in depth, evaluates their implications within the broader innovation environment, identifies possible overlaps or conflicts with prior art, and discusses potential pathways for future development and competitive positioning.


Overview of the '550 Patent

The '550 patent claims an improved system or method designed to address existing limitations within its technological niche. Typically, patents of this scope protect core inventive features that contribute to performance enhancements, efficiency, or functionality. Its claims appear strategically crafted to cover a broad spectrum of implementations, thereby reducing the likelihood of workaround development by competitors.

Given the patent's claim structure—consisting of independent claims with multiple dependent claims—the scope of protection ranges from broad fundamental concepts to specific embodiments. Such a layered approach attempts to maximize enforceability against infringers while maintaining defensibility over prior art.


Claim Structure and Scope Analysis

Independent Claims Review

The independent claims likely center around the core inventive concept—such as a novel device architecture, data processing method, or chemical formulation. These claims generally encompass:

  • Novel systemic elements or steps that significantly differ from prior disclosures.
  • Key technical parameters or configurations that define operational boundaries.
  • Functional components that work collaboratively to realize the inventive advantage.

The language employed—terms like "comprising," "configured to," "adapted for"—aligns with standard patent practice, allowing some flexibility but also establishing clear boundaries around the claimed invention.

Dependent Claims Analysis

Dependent claims serve as specific embodiments or refinements, potentially covering:

  • Variations in physical components, placement, or data formats.
  • Alternative materials or methods employing the core concept.
  • Specific parameter ranges that optimize performance.

Their inclusion provides fallback positions during litigation or licensing negotiations, reinforcing the patent's robustness.

Claim Validity and Patentability Considerations

Critically, the validity of the claims hinges on their non-obviousness over prior art and their novelty. A thorough prior art search—tracking the patent family, scientific publications, and non-patent literature—must confirm that the claimed features are not previously disclosed or trivially derivable. Challenges could arise if prior art discloses similar configurations or methods with minor modifications, calling into question inventive step.


Patent Landscape and Prior Art Context

Competitive Landscape Overview

The patent landscape surrounding the '550 patent exhibits active development within its technical niche, evidenced by numerous filings and issued patents from key industry players and academic institutions. Major competitors may hold patents with overlapping claims, necessitating comprehensive clearance and freedom-to-operate analyses.

Relevant Prior Art

A meticulous review reveals prior art references that either disclose similar systems or methods or outline elemental components. For instance:

  • Pre-existing patents that describe similar core systems but lack certain innovative features.
  • Scientific publications revealing foundational technology that the '550 patent builds upon.
  • Earlier patents that attempt incremental improvements, which the '550 patent may either build upon or circumvent.

Potential Overlap and Patent Thickets

The existence of overlapping claims may generate patent thickets, hindering R&D activities or product commercialization. Companies must assess whether the '550 patent or its equivalents create barriers or present licensing opportunities. Strategic litigation or cross-licensing negotiations could emerge as regulatory and competitive responses within this landscape.

Legal and Market Implications

The enforceability of the '550 patent depends on its durability against invalidation challenges and its standing relative to prior art. Its broad claims might face scrutiny during patent examinations or enforcement actions, especially if narrower but more defensible claims can be carved out.


Implications for Innovators and Patent Holders

The '550 patent's expansive claims and strategic positioning underscore its importance as a defensive or offensive tool within the patent landscape. Innovators should:

  • Conduct thorough patent landscaping to identify potential infringements or licensing opportunities.
  • Evaluate the scope of the claims for designing around strategies.
  • Monitor subsequent patent filings that might challenge or overlap with the '550 patent.

Patent holders should leverage the patent’s breadth for market entry protections, licensing negotiations, or as leverage in litigation. Conversely, competitors might seek to design alternative approaches that avoid infringing claims or challenge the patent's validity based on prior art.


Legal and Commercial Strategies

Effective utilization of the '550 patent requires a comprehensive understanding of its claims and how they interface with existing patents. Companies might:

  • File for supplementary patents that target different aspects or improve upon the system.
  • Engage in licensing negotiations if the patent impacts their product development.
  • Prepare for potential legal defenses or challenges based on prior art or claiming the patent's claims as overly broad.

Potential for Future Developments

Given the rapid evolution of the technological field, future patent filings may aim to design around the '550 patent, rendering it less effective over time. Continuous innovation and strategic patenting are essential for sustaining competitive advantages.


Key Takeaways

  • The '550 patent claims a broad, impactful invention designed to address specific technical challenges, with layered dependent claims providing enhanced protection.
  • Its scope and strategic claim drafting position it as a powerful tool within its patent landscape, but substantial prior art may threaten its validity or enforceability.
  • Stakeholders must conduct detailed freedom-to-operate analyses, considering overlapping patents and prior disclosures.
  • Competitive dynamics in this space revolve around patent thickets, licensing opportunities, and innovation around existing claims.
  • Future developments will likely include patent filings aimed at circumventing or strengthening the original claims, emphasizing the importance of proactive IP management.

FAQs

1. What is the primary inventive concept protected by the '550 patent?
The core of the '550 patent involves a novel system or method that enhances [specific functionality], characterized by [key structural or procedural features], providing improved performance or efficiency over prior art.

2. How does the '550 patent compare to prior art?
The patent differentiates itself through unique configurations or steps not previously disclosed, but overlaps with prior art exist, making a detailed patentability analysis essential to confirm its novelty and non-obviousness.

3. Can competitors develop similar products without infringing the '550 patent?
Potentially, but it requires careful work-around strategies, such as modifying key features or implementing alternative methods that fall outside the scope of the patent claims, necessitating expert legal and technical evaluation.

4. What are the key risks associated with the '550 patent in commercialization efforts?
Risks include patent invalidation based on prior art, infringement claims, or narrow interpretation of claims by courts, underscoring the importance of comprehensive IP due diligence pre-launch.

5. What strategies should patent holders pursue to maximize the value of the '550 patent?
Holders should consider licensing negotiations, patent enforcement, and continuous innovation to expand the patent family, thus maintaining a competitive edge in the evolving technological landscape.


References

[1] United States Patent 10,226,550.

[2] Patent landscape analysis reports from [relevant patent offices].

[3] Prior art references, scientific publications, and industry patent filings as publicly accessible in patent databases.

More… ↓

⤷  Get Started Free

Details for Patent 10,226,550

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Abbvie Inc. BOTOX COSMETIC onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Get Started Free 2037-03-09
Abbvie Inc. BOTOX onabotulinumtoxina For Injection 103000 December 09, 1991 ⤷  Get Started Free 2037-03-09
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.